| scholarly article | Q13442814 |
| P50 | author | Kai Jiao | Q73746112 |
| P2093 | author name string | Qin Wang | |
| Christopher Booth | |||
| Jin Zhang | |||
| Venetia Zachariou | |||
| Hongxia Wang | |||
| Yunjia Chen | |||
| Dimitra Terzi | |||
| Raymond X Wang | |||
| P2860 | cites work | Molecular basis for subtype-specific desensitization of inhibitory adenosine receptors. Analysis of a chimeric A1-A3 adenosine receptor | Q71143471 |
| Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions | Q73812616 | ||
| Negative cross-talk between presynaptic adenosine and acetylcholine receptors | Q79790870 | ||
| Targeting protein phosphatase 1 (PP1) to the actin cytoskeleton: the neurabin I/PP1 complex regulates cell morphology | Q24537519 | ||
| The postsynaptic density proteins Homer and Shank form a polymeric network structure | Q24645689 | ||
| Neurabin: a novel neural tissue-specific actin filament-binding protein involved in neurite formation | Q24678330 | ||
| Neurabin is a synaptic protein linking p70 S6 kinase and the neuronal cytoskeleton | Q24685127 | ||
| Role of PDZ proteins in regulating trafficking, signaling, and function of GPCRs: means, motif, and opportunity | Q27015870 | ||
| GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins | Q28145018 | ||
| Brain actin-associated protein phosphatase 1 holoenzymes containing spinophilin, neurabin, and selected catalytic subunit isoforms | Q28576201 | ||
| Cellular regulation of RGS proteins: modulators and integrators of G protein signaling | Q28646133 | ||
| Endogenous regulators of G protein signaling proteins regulate presynaptic inhibition at rat hippocampal synapses | Q28776561 | ||
| Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. | Q31804337 | ||
| Functions of neuronal adenosine receptors | Q34101843 | ||
| Regulators of G-protein signalling as new central nervous system drug targets. | Q34139169 | ||
| The role and regulation of adenosine in the central nervous system | Q34205330 | ||
| Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system | Q34302183 | ||
| Thinking outside of the "RGS box": new approaches to therapeutic targeting of regulators of G protein signaling. | Q34310119 | ||
| α(2A) adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction | Q34661158 | ||
| Purines and neuroprotection | Q35063078 | ||
| How regulators of G protein signaling achieve selective regulation | Q35652043 | ||
| Systematic Prediction of Scaffold Proteins Reveals New Design Principles in Scaffold-Mediated Signal Transduction | Q35783033 | ||
| A finer tuning of G-protein signaling through regulated control of RGS proteins | Q36115328 | ||
| Cellular mechanisms that determine selective RGS protein regulation of G protein-coupled receptor signaling | Q36463487 | ||
| Roles for Regulator of G Protein Signaling Proteins in Synaptic Signaling and Plasticity | Q36502948 | ||
| Adenosine as a neuromodulator in neurological diseases | Q36974004 | ||
| Adenosine receptors and the central nervous system. | Q37565205 | ||
| GPCR interacting proteins (GIPs) in the nervous system: Roles in physiology and pathologies | Q37670210 | ||
| Minireview: Role of intracellular scaffolding proteins in the regulation of endocrine G protein-coupled receptor signaling | Q38459674 | ||
| Regulated interactions of the alpha 2A adrenergic receptor with spinophilin, 14-3-3zeta, and arrestin 3. | Q40698015 | ||
| Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells | Q41727077 | ||
| Neurabin scaffolding of adenosine receptor and RGS4 regulates anti-seizure effect of endogenous adenosine. | Q41775962 | ||
| Differential desensitization of responses mediated by presynaptic and postsynaptic A1 adenosine receptors. | Q43890669 | ||
| Endogenous RGS proteins and Galpha subtypes differentially control muscarinic and adenosine-mediated chronotropic effects. | Q46925910 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 630-639 | |
| P577 | publication date | 2017-09-27 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | Effective Attenuation of Adenosine A1R Signaling by Neurabin Requires Oligomerization of Neurabin | |
| P478 | volume | 92 |
| Q92114438 | Research progress on adenosine in central nervous system diseases | cites work | P2860 |
Search more.